KEGG   ORTHOLOGY: K07965
Entry
K07965                      KO                                     

Name
HPSE2
Definition
heparanase 2 [EC:3.2.1.-]
Pathway
ko00531  Glycosaminoglycan degradation
ko01100  Metabolic pathways
ko05205  Proteoglycans in cancer
Module
M00078  Heparan sulfate degradation
Disease
H00753  Urofacial syndrome
Brite
KEGG Orthology (KO) [BR:ko00001]
 09100 Metabolism
  09107 Glycan biosynthesis and metabolism
   00531 Glycosaminoglycan degradation
    K07965  HPSE2; heparanase 2
 09160 Human Diseases
  09161 Cancer: overview
   05205 Proteoglycans in cancer
    K07965  HPSE2; heparanase 2
 09180 Brite Hierarchies
  09183 Protein families: signaling and cellular processes
   00536 Glycosaminoglycan binding proteins
    K07965  HPSE2; heparanase 2
Enzymes [BR:ko01000]
 3. Hydrolases
  3.2  Glycosylases
   3.2.1  Glycosidases, i.e. enzymes that hydrolyse O- and S-glycosyl compounds
    3.2.1.-  
     K07965  HPSE2; heparanase 2
Glycosaminoglycan binding proteins [BR:ko00536]
 Heparan sulfate / Haparin
  Enzymes
   K07965  HPSE2; heparanase 2
Other DBs
RN: R07811
GO: 0030305
Genes
HSA: 60495(HPSE2)
PTR: 466176(HPSE2)
PPS: 100989887(HPSE2)
GGO: 101129718(HPSE2)
PON: 100437923(HPSE2)
NLE: 100595775(HPSE2)
MCC: 708795(HPSE2)
MCF: 102138349(HPSE2)
CSAB: 103216367(HPSE2)
RRO: 104682796(HPSE2)
RBB: 108534921(HPSE2)
CJC: 100407598(HPSE2)
SBQ: 101048909(HPSE2)
MMU: 545291(Hpse2)
MCAL: 110285549(Hpse2)
MPAH: 110318165(Hpse2)
RNO: 368128(Hpse2)
MUN: 110550503(Hpse2)
NGI: 103733180(Hpse2)
HGL: 101712098(Hpse2)
CCAN: 109699884(Hpse2)
OCU: 100359235(HPSE2)
TUP: 102495912(HPSE2)
CFA: 486831(HPSE2)
VVP: 112914666(HPSE2)
AML: 105236608(HPSE2)
UMR: 103675767(HPSE2)
UAH: 113251812(HPSE2)
ELK: 111145067
FCA: 101083879(HPSE2)
PTG: 102953291(HPSE2)
PPAD: 109272743(HPSE2)
AJU: 106966932(HPSE2)
BTA: 537343(HPSE2)
BOM: 102270609(HPSE2)
BIU: 109553225(HPSE2)
BBUB: 102407242(HPSE2)
CHX: 102177683(HPSE2)
SSC: 100157983(HPSE2)
CFR: 102517296(HPSE2)
CDK: 105084300(HPSE2)
BACU: 102998284(HPSE2)
LVE: 103073307(HPSE2)
OOR: 101276584(HPSE2)
DLE: 111172629(HPSE2)
PCAD: 102996398(HPSE2)
ECB: 100070602(HPSE2)
EPZ: 103562175(HPSE2)
EAI: 106847003
MYB: 102240000(HPSE2)
MYD: 102764410
MNA: 107542562(HPSE2)
HAI: 109379685(HPSE2)
PALE: 102881775(HPSE2)
RAY: 107520389(HPSE2)
MJV: 108385480(HPSE2)
LAV: 100666920(HPSE2)
TMU: 101359421
MDO: 100020982(HPSE2)
SHR: 100926861(HPSE2)
PCW: 110215367(HPSE2)
OAA: 100076734(HPSE2)
GGA: 423834(HPSE2)
MGP: 104912019(HPSE2)
CJO: 107316031(HPSE2)
NMEL: 110399795(HPSE2)
APLA: 101794162(HPSE2)
ACYG: 106037073(HPSE2)
TGU: 100228540(HPSE2)
LSR: 110473683(HPSE2)
SCAN: 103814162(HPSE2)
FAB: 101819889(HPSE2)
PHI: 102111700(HPSE2)
PMAJ: 107206892(HPSE2)
CCAE: 111931223(HPSE2)
CCW: 109145966(HPSE2)
ETL: 114070959(HPSE2)
FPG: 101917114(HPSE2)
FCH: 102058821(HPSE2)
CLV: 102088744
EGZ: 104129081(HPSE2)
NNI: 104013727(HPSE2)
ACUN: 113481582(HPSE2)
PADL: 103916340(HPSE2)
AAM: 106494693(HPSE2)
ASN: 102380123(HPSE2)
AMJ: 102560537(HPSE2)
CMY: 102946175(HPSE2)
CPIC: 101951758(HPSE2)
ACS: 100564973(hpse2)
PVT: 110084049(HPSE2)
PBI: 103059374(HPSE2)
PMUR: 107287746(HPSE2)
TSR: 106548177(HPSE2)
PMUA: 114597604(HPSE2)
GJA: 107114417(HPSE2) 107121129
XLA: 108696172(hpse2.L)
XTR: 100485493(hpse2)
NPR: 108787514(HPSE2)
DRE: 562573(hpse2)
SGH: 107586094 107601035(hpse2)
IPU: 108262814(hpse2)
PHYP: 113545209(hpse2)
AMEX: 103034333(hpse2)
EEE: 113585908(hpse2)
TRU: 101080039(hpse2)
LCO: 104930784(hpse2)
NCC: 104955141(hpse2)
MZE: 101464618(hpse2)
ONL: 100704811(hpse2)
OLA: 101164248(hpse2)
XMA: 102220259(hpse2)
XCO: 114138527(hpse2)
PRET: 103476909(hpse2)
CVG: 107088632(hpse2)
NFU: 107375674(hpse2)
KMR: 108233958(hpse2)
ALIM: 106528207(hpse2)
AOCE: 111578274(hpse2)
CSEM: 103387298(hpse2)
POV: 109631478(hpse2)
LCF: 108884124(hpse2)
SDU: 111235152(hpse2)
SLAL: 111654696(hpse2)
HCQ: 109512722(hpse2)
BPEC: 110156904(hpse2)
MALB: 109961145(hpse2)
SASA: 106612917(hpse2)
SALP: 112080523
ELS: 105021381(hpse2)
SFM: 108942734(hpse2)
PKI: 111849601(hpse2)
LCM: 102359157(HPSE2)
CMK: 103188922(hpse2)
RTP: 109913676
 » show all
Reference
PMID:1027606
  Authors
Mehta PV
  Title
Value of cyclic hormonal assessment by vaginal cytology in infertile women.
  Journal
J Obstet Gynaecol India 26:111-6 (1976)
  Sequence
[hsa:60495]

KEGG   REACTION: R07811
Entry
R07811                      Reaction                               

Definition
Heparan sulfate + H2O <=> Heparan sulfate + G13034
Equation
Enzyme
3.2.1.166       3.2.1.-
Pathway
rn00531  Glycosaminoglycan degradation
rn01100  Metabolic pathways
Module
M00078  Heparan sulfate degradation
Orthology
K07964  heparanase [EC:3.2.1.166]
K07965  heparanase 2 [EC:3.2.1.-]

DBGET integrated database retrieval system